CTT Pharmaceutical Holdings, Inc.

OTCPK:CTTH Stock Report

Market Cap: US$2.9m

CTT Pharmaceutical Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:CTTH Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
09 Apr 25BuyUS$649Ryan KhouriIndividual9,984US$0.065
31 Mar 25BuyUS$776Ryan KhouriIndividual15,510US$0.05
11 Mar 25BuyUS$324Ryan KhouriIndividual5,400US$0.06
07 Mar 25BuyUS$1,076Ryan KhouriIndividual11,950US$0.09
05 Feb 25BuyUS$624Mindesta Inc.Company5,200US$0.12
25 Nov 24BuyUS$1,401Mindesta Inc.Company23,346US$0.06
11 Sep 24BuyUS$61Mindesta Inc.Company1,100US$0.055
11 Sep 24BuyUS$41Mindesta Inc.Company750US$0.055
27 Aug 24BuyUS$33Mindesta Inc.Company550US$0.06
19 Aug 24BuyUS$145Mindesta Inc.Company2,900US$0.05
12 Aug 24BuyUS$52Ryan KhouriIndividual1,300US$0.04
06 Aug 24BuyUS$92Ryan KhouriIndividual2,200US$0.042
05 Aug 24BuyUS$42Ryan KhouriIndividual1,000US$0.042
03 Aug 24BuyUS$60Mindesta Inc.Company1,000US$0.06
01 Aug 24BuyUS$64Ryan KhouriIndividual1,600US$0.04
26 Jul 24BuyUS$124Ryan KhouriIndividual3,100US$0.04
24 Jul 24BuyUS$68Ryan KhouriIndividual1,700US$0.04
18 Jul 24BuyUS$100Ryan KhouriIndividual2,000US$0.05
16 Jul 24BuyUS$108Ryan KhouriIndividual1,800US$0.06
11 Jul 24BuyUS$164Ryan KhouriIndividual2,730US$0.06
11 Jul 24BuyUS$64Ryan KhouriIndividual1,070US$0.06
05 Jul 24BuyUS$87Ryan KhouriIndividual1,454US$0.06
20 Jun 24BuyUS$70Ryan KhouriIndividual1,000US$0.07
03 Jun 24BuyUS$148Mindesta Inc.Company7,376US$0.02
21 May 24BuyUS$84Mindesta Inc.Company3,236US$0.026

Insider Trading Volume

Insider Buying: CTTH insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CTTH?
Owner TypeNumber of SharesOwnership Percentage
Public Companies00%
Individual Insiders6,600,40011.5%
General Public50,676,83288.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 1 shareholders own 11.52% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.5%
Ryan Khouri
6,600,400US$336.6k31%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/16 09:20
End of Day Share Price 2025/05/16 00:00
Earnings2015/09/30
Annual Earnings2014/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CTT Pharmaceutical Holdings, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.